
    
      The hepatitis B virus ( HBV ) is a global health problem . It is estimated that in the world
      there are about 350-400 million carriers of HBV surface antigen ( HBsAg ) 1 .

      The prevalence in Spain is estimated at a 2-7 % and is considered a second intermediate
      prevalence.

      For over 20 years, has carried out a program of primary prevention through universal
      vaccination against hepatitis B including it in the childhood vaccination schedule and has
      already been observed that in some estudi3 the prevalence has declined . For this reason , we
      want to evaluate what is the currently prevalence in our area of influence. There aren't
      recent studies to assess what is the current status of these patients ( how many , what risk
      factors which needs of treatment and with answer ...)
    
  